- Health Conditions
- Events
- MedWire
- Visit A Doctor
- Medimorphosis
- HCP Portal
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Medication & Drugs
The COVID-19 pandemic is an ongoing global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of 21…
The growing biologic armamentarium of plaque psoriasis treatment: A review of risankizumab (Skyrizi)
Psoriasis can affect far more than the skin. New biologics like risankizumab target the IL-23 pathway, with trials showing high rates of skin clearance and sustained results for patients with moderate-to-severe plaque psoriasis.
Log In or Register as a healthcare professional to read the full article.
Psoriasis affects more than 40,000 people in Singapore and can lead to joint and cardiovascular complications. Clinical trials show the IL-17 inhibitor ixekizumab delivering strong skin clearance, shaping how moderate-to-severe psoriasis is treated.
Log In or Register as a healthcare professional to read the full article.
Subscribe to Updates
Subscribe to receive latest health related news from us
Copyright © Medical Channel Asia 2024.
All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.